| NCT ID | NCT06605989 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul National University Hospital |
| Condition | Nasotracheal Intubation |
| Study Type | INTERVENTIONAL |
| Enrollment | 208 participants |
| Start Date | 2024-09-26 |
| Primary Completion | 2026-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 208 participants in total. It began in 2024-09-26 with a primary completion date of 2026-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the study is to investigate the effect of the nostril side on epistaxis during nasotracheal intubation.
Eligibility Criteria
Inclusion Criteria: * adult patients requiring nasotracheal intubation for elective surgery Exclusion Criteria: * refuse to participate in the study * severe deformity in the nose * current severe epistaxis * cannot insert the tube into a specific nostril side due to any reason
Contact & Investigator
Jung-Man Lee, M.D.,Ph.D.
PRINCIPAL INVESTIGATOR
Seoul National University College of Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center
Frequently Asked Questions
Who can join the NCT06605989 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, studying Nasotracheal Intubation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06605989 currently recruiting?
Yes, NCT06605989 is actively recruiting participants. Contact the research team at jungman007@gmail.com for enrollment information.
Where is the NCT06605989 trial being conducted?
This trial is being conducted at Seoul, South Korea, Seoul, South Korea.
Who is sponsoring the NCT06605989 clinical trial?
NCT06605989 is sponsored by Seoul National University Hospital. The principal investigator is Jung-Man Lee, M.D.,Ph.D. at Seoul National University College of Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center. The trial plans to enroll 208 participants.